Biotechnology stocks
1,362 listed biotechnology companies, ordered by market capitalisation, inside the Health Care sector. Every one has a free page with its price history, key figures and Tweenvest factor scores.
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $484.83B | $283.50 | +3.33% |
| Amgen Inc.NasdaqGS: AMGN | $223.19B | $427.00 | +3.43% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $183.41B | $153.05 | +3.47% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $122.98B | $500.05 | +3.06% |
| Moderna, Inc.NasdaqGS: MRNA | $86.33B | $226.20 | +4.60% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $75.20B | $777.14 | +3.19% |
| CSL LimitedASX: CSL | $61.74B | AU$184.58 | -0.12% |
| Natera, Inc.NasdaqGS: NTRA | $57.03B | $395.73 | +0.02% |
| argenx SEENXTBR: ARGX | $50.31B | €746.20 | +3.84% |
| Revolution Medicines, Inc.NasdaqGS: RVMD | $40.39B | $193.42 | +2.64% |
| BeOne Medicines AGNasdaqGS: ONC | $39.69B | $349.08 | -0.38% |
| Biogen Inc.NasdaqGS: BIIB | $33.82B | $233.04 | +1.81% |
| Celltrion, Inc.KOSE: A068270 | $30.52B | ₩179,600.00 | -1.64% |
| Alnylam Pharmaceuticals, Inc.NasdaqGS: ALNY | $29.95B | $224.22 | +0.18% |
| Roivant Sciences Ltd.NasdaqGS: ROIV | $24.09B | $33.67 | +0.96% |
| United Therapeutics CorporationNasdaqGS: UTHR | $23.31B | $541.31 | -0.38% |
| BioNTech SENasdaqGS: BNTX | $22.36B | $88.79 | -0.25% |
| Genmab A/SCPSE: GMAB | $22.10B | Dkr2,481.00 | +0.45% |
| Incyte CorporationNasdaqGS: INCY | $22.02B | $111.33 | +2.49% |
| Insmed IncorporatedNasdaqGS: INSM | $21.14B | $97.47 | +0.70% |
| Innovent Biologics, Inc.SEHK: 1801 | $20.40B | HK$91.95 | -0.16% |
| PharmaEssentia CorporationTWSE: 6446 | $15.49B | NT$1,195.00 | +2.58% |
| Swedish Orphan Biovitrum AB (publ)OM: SOBI | $14.91B | Skr437.40 | +2.10% |
| Exelixis, Inc.NasdaqGS: EXEL | $14.75B | $60.71 | +2.02% |
| Ascendis Pharma A/SNasdaqGS: ASND | $14.66B | $227.08 | +1.73% |
| Neurocrine Biosciences, Inc.NasdaqGS: NBIX | $13.74B | $135.47 | +0.25% |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.SEHK: 6990 | $13.70B | HK$450.00 | +0.04% |
| Akeso, Inc.SEHK: 9926 | $12.81B | HK$109.10 | +2.15% |
| ALTEOGEN Inc.KOSDAQ: A196170 | $12.48B | ₩241,000.00 | -7.13% |
| Halozyme Therapeutics, Inc.NasdaqGS: HALO | $12.44B | $117.06 | +6.79% |
| Summit Therapeutics Inc.NasdaqGM: SMMT | $12.41B | $15.11 | -2.64% |
| BridgeBio Pharma, Inc.NasdaqGS: BBIO | $12.37B | $64.66 | +2.15% |
| Madrigal Pharmaceuticals, Inc.NasdaqGS: MDGL | $10.90B | $458.18 | -2.88% |
| BioMarin Pharmaceutical Inc.NasdaqGS: BMRN | $10.53B | $55.11 | +1.34% |
| Vaxcyte, Inc.NasdaqGS: PCVX | $10.51B | $67.41 | +0.91% |
| ImmunityBio, Inc.NasdaqGS: IBRX | $10.39B | $10.25 | +4.59% |
| Krystal Biotech, Inc.NasdaqGS: KRYS | $9.51B | $328.00 | +2.13% |
| Twist Bioscience CorporationNasdaqGS: TWST | $9.49B | $149.31 | -1.33% |
| Kymera Therapeutics, Inc.NasdaqGM: KYMR | $9.35B | $105.69 | -5.97% |
| Protagonist Therapeutics, Inc.NasdaqGM: PTGX | $8.96B | $136.52 | -1.42% |
| Cytokinetics, IncorporatedNasdaqGS: CYTK | $8.57B | $63.26 | +2.66% |
| Caris Life Sciences, Inc.NasdaqGS: CAI | $8.35B | $30.37 | +2.84% |
| Arrowhead Pharmaceuticals, Inc.NasdaqGS: ARWR | $8.21B | $58.03 | -0.17% |
| Spyre Therapeutics, Inc.NasdaqGS: SYRE | $8.01B | $78.69 | -8.17% |
| TG Therapeutics, Inc.NasdaqCM: TGTX | $7.85B | $54.33 | -1.88% |
| RemeGen Co., Ltd.SEHK: 9995 | $7.56B | HK$70.40 | -3.43% |
| ABIVAX Société AnonymeENXTPA: ABVX | $7.51B | €76.95 | -1.60% |
| Praxis Precision Medicines, Inc.NasdaqGS: PRAX | $7.26B | $238.05 | -8.39% |
| Ionis Pharmaceuticals, Inc.NasdaqGS: IONS | $7.04B | $42.54 | +0.38% |
| Biocytogen Pharmaceuticals (Beijing) Co., Ltd.SEHK: 2315 | $6.75B | HK$69.20 | +2.59% |
| Gan & Lee Pharmaceuticals.SHSE: 603087 | $6.71B | CN¥75.52 | -2.43% |
| Alkermes plcNasdaqGS: ALKS | $6.67B | $38.99 | -1.86% |
| Iovance Biotherapeutics, Inc.NasdaqGM: IOVA | $6.57B | $14.18 | -2.27% |
| Grifols, S.A.BME: GRF | $6.52B | €9.81 | +0.10% |
| GRAIL, Inc.NasdaqGS: GRAL | $6.27B | $138.76 | -1.13% |
| Kodiak Sciences Inc.NasdaqGM: KOD | $6.26B | $81.98 | -17.91% |
| Rhythm Pharmaceuticals, Inc.NasdaqGM: RYTM | $6.25B | $86.59 | -4.62% |
| Kiniksa Pharmaceuticals International, plcNasdaqGS: KNSA | $6.13B | $79.03 | +0.64% |
| Immunovant, Inc.NasdaqGS: IMVT | $5.93B | $27.91 | -2.79% |
| Biocon LimitedNSEI: BIOCON | $5.88B | Rs349.40 | -5.75% |
| Mirum Pharmaceuticals, Inc.NasdaqGM: MIRM | $5.58B | $79.09 | -8.05% |
| CG Oncology, Inc.NasdaqGS: CGON | $5.53B | $62.16 | -0.38% |
| Oruka Therapeutics, Inc.NasdaqCM: ABIO | $5.44B | $— | — |
| Oruka Therapeutics, Inc.NasdaqGM: ORKA | $5.44B | $76.89 | -6.36% |
| Erasca, Inc.NasdaqGS: ERAS | $5.17B | $14.58 | -1.35% |
| Sunshine Guojian Pharmaceutical (Shanghai) Co., LtdSHSE: 688336 | $5.10B | CN¥38.10 | -8.04% |
| Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.SHSE: 603392 | $5.09B | CN¥26.96 | -1.39% |
| PTC Therapeutics, Inc.NasdaqGS: PTCT | $5.00B | $59.35 | -0.95% |
| Shanghai RAAS Blood Products Co., Ltd.SZSE: 002252 | $4.98B | CN¥5.06 | -4.89% |
| Scholar Rock Holding CorporationNasdaqGS: SRRK | $4.93B | $39.77 | -1.85% |
| Travere Therapeutics, Inc.NasdaqGM: TVTX | $4.91B | $53.04 | +1.76% |
| Chongqing Zhifei Biological Products Co., Ltd.SZSE: 300122 | $4.90B | CN¥13.70 | -2.00% |
| Cogent Biosciences, Inc.NasdaqGS: COGT | $4.88B | $28.06 | -0.12% |
| CRISPR Therapeutics AGNasdaqGM: CRSP | $4.84B | $50.18 | +0.16% |
| 3SBio Inc.SEHK: 1530 | $4.69B | HK$14.76 | +0.20% |
| Lin BioScience, Inc.TPEX: 6696 | $4.54B | NT$175.00 | -3.58% |
| Shanghai Junshi Biosciences Co., Ltd.SEHK: 1877 | $4.45B | HK$17.65 | -2.32% |
| Dianthus Therapeutics, Inc.NasdaqCM: DNTH | $4.34B | $74.64 | -3.79% |
| Imeik Technology Development Co.,Ltd.SZSE: 300896 | $4.19B | CN¥92.96 | -1.22% |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd.SHSE: 688192 | $4.16B | CN¥59.95 | +3.34% |
| Suzhou Zelgen Biopharmaceuticals Co., Ltd.SHSE: 688266 | $4.12B | CN¥104.25 | -5.23% |
| Tango Therapeutics, Inc.NasdaqGM: TNGX | $4.01B | $21.97 | -7.73% |
| Relay Therapeutics, Inc.NasdaqGM: RLAY | $3.80B | $17.12 | -1.38% |
| Beijing Tiantan Biological Products Co., Ltd.SHSE: 600161 | $3.76B | CN¥12.73 | +1.11% |
| Telix Pharmaceuticals LimitedASX: TLX | $3.74B | AU$15.78 | -3.19% |
| Hualan Biological Engineering Inc.SZSE: 002007 | $3.64B | CN¥13.35 | +0.07% |
| Veracyte, Inc.NasdaqGM: VCYT | $3.64B | $43.24 | -4.41% |
| Xenon Pharmaceuticals Inc.NasdaqGM: XENE | $3.53B | $33.77 | -7.34% |
| Shanghai Henlius Biotech, Inc.SEHK: 2696 | $3.53B | HK$50.75 | -13.10% |
| Walvax Biotechnology Co., Ltd.SZSE: 300142 | $3.52B | CN¥14.75 | +3.65% |
| Legend Biotech CorporationNasdaqGS: LEGN | $3.46B | $19.44 | +8.72% |
| InnoCare Pharma LimitedSEHK: 9969 | $3.46B | HK$12.73 | -6.60% |
| CareDx, Inc.NasdaqGM: CDNA | $3.38B | $65.00 | -0.66% |
| Celcuity Inc.NasdaqCM: CELC | $3.32B | $60.25 | -11.32% |
| IDEAYA Biosciences, Inc.NasdaqGS: IDYA | $3.31B | $33.72 | -1.58% |
| Arcutis Biotherapeutics, Inc.NasdaqGS: ARQT | $3.28B | $26.50 | +1.57% |
| Acadia Pharmaceuticals Inc.NasdaqGS: ACAD | $3.21B | $19.17 | +2.95% |
| Viking Therapeutics, Inc.NasdaqCM: VKTX | $3.11B | $25.56 | -4.09% |
| Acrobiosystems Co.,Ltd.SZSE: 301080 | $3.06B | CN¥122.20 | -13.38% |
| Denali Therapeutics Inc.NasdaqGS: DNLI | $2.94B | $17.82 | -3.18% |